Farzad Nasri
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- MicroRNA in disease regulation
Papers in
-
- Galectins and Cancer Biology 2
- Immune cells in cancer 1
-
- Acute Myeloid Leukemia Research 1
- Co-authors
- Pouria Khani (6 shared papers)Reza Falak (4 shared papers)Nafiseh Behranvand (3 shared papers)Reza Zolfaghari Emameh (1 shared paper)Asieh Hosseini (1 shared paper)Johan Garssen (1 shared paper)Hamed Mirzaei (2 shared papers)Javid Sadri Nahand (1 shared paper)
- Journals
- Research in Pharmaceutical Sciences (1 paper)Journal of Neurochemistry (1 paper)Frontiers in Genetics (1 paper)Cancer Immunology Immunotherapy (1 paper)Cancer Cell International (1 paper)
- Partner nations
- IranRussiaNetherlands
In The Last Decade
Farzad Nasri
9 papers receiving 455 citations
Farzad Nasri's Hit Papers
Peers
Comparison fields: 5 of 71
- Biomaterials 62
- Cancer Research 49
- Oncology 55
- Molecular Medicine 15
- Genetics 17
Countries citing papers authored by Farzad Nasri
This map shows the geographic impact of Farzad Nasri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzad Nasri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzad Nasri more than expected).
Fields of papers citing papers by Farzad Nasri
This network shows the impact of papers produced by Farzad Nasri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzad Nasri. The network helps show where Farzad Nasri may publish in the future.
Co-authors
The 23 scholars most cited alongside Farzad Nasri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy: a double-edged sword in cancer treatment Hit paper breakdown → | 2021 | 295 |
| 2 | 2018 | 87 | |
| 3 | 2018 | 22 | |
| 4 | 2024 | 17 | |
| 5 | 2025 | 13 | |
| 6 | 2020 | 11 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 5 | |
| 9 | 2025 | 2 | |
| 10 | 2023 | 0 |
About Farzad Nasri
Farzad Nasri is a scholar working on Immunology, Hematology, Immunology and Allergy, Genetics and Cancer Research, having authored 10 papers that have together received 462 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Skin and Cellular Biology Research (1 paper), Acute Myeloid Leukemia Research (1 paper), Immune cells in cancer (1 paper), Glioma Diagnosis and Treatment (1 paper) and Neurotransmitter Receptor Influence on Behavior (1 paper). The work is most often cited by research in Biomaterials (62 citations), Cancer Research (49 citations), Oncology (55 citations), Molecular Medicine (15 citations) and Genetics (17 citations). Farzad Nasri has collaborated with scholars based in Iran, Russia and Netherlands. Frequent co-authors include Pouria Khani, Reza Falak, Nafiseh Behranvand, Reza Zolfaghari Emameh, Asieh Hosseini, Johan Garssen, Hamed Mirzaei, Javid Sadri Nahand, Ali Zekri and Farideh Ghazi. Their work appears in journals such as Research in Pharmaceutical Sciences, Journal of Neurochemistry, Frontiers in Genetics, Cancer Immunology Immunotherapy and Cancer Cell International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.